Mauro Chies

Mauro Chies

executive Canada

Mauro Chies is the Chief Executive Officer of the pan-Canadian Pharmaceutical Alliance (pCPA), an organization that negotiates drug prices on behalf of federal and provincial public insurance plans in Canada. Under his leadership, the pCPA has saved considerable amounts in drug spending through collective negotiations with pharmaceutical manufacturers. Chies has expressed concerns that new pricing policies from the U.S. could lead to higher drug prices in Canada, potentially straining the healthcare system.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Canada Canada: Chief executive officer Mauro Chies said in a statement that drug price negotiations are confidential as agreed upon by both the pCPA and the manufacturers. 5

The Globe and Mail: U.S. pushes drugmakers to reveal confidential details of contracts with Canada, other countries

Canada Canada: Mauro Chies, chief executive officer of the pCPA, said the goal is for pricing negotiations to run over three or four months. 7

The Globe and Mail: Ontario to offer early access to some new cancer drugs in pilot project

Canada Canada: Mauro Chies, chief executive officer of the pCPA, said he expects pharmaceutical companies to honour the pricing terms on existing agreements. 5

The Globe and Mail: Trump says new order will lower U.S. drug prices and increase them everywhere else